Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lessons from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can We Fuel the Tumor Microenvironment in Gliomas?

Vaccines(2024)10.3390/vaccines12080862Source: DataRank Database

Lessons from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can We Fuel the Tumor Microenvironment in Gliomas? is a research paper published in Vaccines (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.27)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Takahide Nejo ORCID,Hideho Okada ORCID,Lan Hoc Phung

Live enrichment

PubMed:39203988 PMC:PMC11359082 OpenAlex:https://openalex.org/W4401210565

NIH/NINDS

Grant: R35NS105068

NIH HHS

Grant: R35NS105068 (H.O.)

FWCI

0.27

Citation Percentile

0.6%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/vaccines12080862

publisherhttps://doi.org/10.3390/vaccines12080862

publisherhttps://www.mdpi.com/2076-393X/12/8/862/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39203988

repositoryhttps://escholarship.org/uc/item/5m62w7pm

Fields of Study

Glioma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersCAR-T cell therapy research

Keywords

ImmunotherapyClinical trialTumor microenvironmentMedicineGliomaBrain tumorCancer immunotherapyOncologyCancerInternal medicineCancer researchPathologyGlioblastomaClinical TrialsNeoadjuvant TreatmentTrial Designs

Sustainable Development Goals

SDG 0: Good health and well-being